Why the study?
False cardiac troponin elevations from non-cardiac causes are a major concern, prompting assessment of terminal renal failure as a possible non-cardiac cause of elevated hs-cTnT concentrations.
Does renal transplantation reduce high-sensitivity cardiac troponin T concentrations in patients with end-stage renal disease?
Does renal transplantation reduce high-sensitivity cardiac troponin T concentrations in patients with end-stage renal disease?
Terminal renal failure contributes to over one-third of high-sensitivity cardiac troponin T elevations in ESRD patients, with the remainder likely due to chronic cardiomyocyte injury.
Answers are grounded in this paper and cite their sources.
Renal transplant associated with rapid hs-cTnT decline in ESRD; supports reversible renal contribution but leaves open CV outcome implications.
BACKGROUND: False cardiac troponin (cTn) elevations from non-cardiac causes are a major concern. We aimed to assess terminal renal failure as a possible non-cardiac cause of elevated high-sensitivity cTnT (hs-cTnT) concentrations using renal transplantation as an in vivo model of rapid restoration of renal function. METHODS: We analysed consecutive patients with end-stage renal disease (ESRD) undergoing renal transplantation at a single centre. Patients with perioperative myocardial infarction or injury were excluded. Changes in hs-cTnT and creatinine were measured pretransplant and at four post-transplant intervals (day 1, days 2-5 and days 14-180). A decrease of ≥25% in hs-cTnT within 24 hours post-transplant was deemed evidence of renal clearance recovery. RESULTS: Among 45 patients (median age 67 years, 31% women), the median pretransplant plasma creatinine concentration was 608 μmol/L (IQR 482-830), and fell to 425 μmol/L (IQR 337-619) on day 1, 289 μmol/L (IQR 201-492) on days 2-5 and 126 μmol/L (IQR 103-191) on days 14-180 (p<0.001, p<0.001 and p=0.003, respectively). The median pretransplant hs-cTnT concentration was 48 ng/L (IQR 34-70). It fell to 26 ng/L (IQR 15-38; geometric mean of relative change 36%) on day 1 (p<0.001) and then remained constant on days 2-5 (26 ng/L (IQR 18-35)) and days 14-180 (25 ng/L (IQR 20-30), p=ns). CONCLUSION: Terminal renal failure is a non-cardiac cause of elevated circulating hs-cTnT concentrations, contributing more than one-third in this cohort, while the remaining two-thirds seem related to chronic cardiomyocyte injury.
No takes yet. Share an insight, caveat, or question.
Papachristou et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: